Antagonistic action between cyclic AMP and estrogen in phosphorylation of mammary tumor nuclear proteins.
A new protein kinase-dependent phosphorylation occurs in the nuclei of hormone-dependent, 7,12-dimethylbenz[alpha]anthracene (DMBA)-induced mammary carcinoma following preincubation of tumor slices with cyclic adenosine 3',5'-monophosphate (cAMP). The presence of 17beta-estradiol in the medium inhibits this effect. Both events have been observed in vivo in the nuclei of DMBA-induced tumors. The phosphorylation pattern of nuclei in hormone-independent mammary tumor, DMBA No. 1, however, is not affected by preincubation with either cAMP or estrogen. These findings suggest that the antagonistic effect of cAMP and estrogen in the growth control of mammary tumors is exerted through a specific action on nuclear protein phosphorylation and that these events correlate with the hormone-dependency of the tumors.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D000242:Cyclic AMP / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D066298:In Vitro Techniques; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000378:metabolism*; D009376:Neoplasms, Hormone-Dependent / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism*; D009698:Nucleoproteins / Q000378:metabolism*; D010766:Phosphorylation; D051381:Rats; D012075:Remission, Spontaneous
D009363:Neoplasm Proteins; D009698:Nucleoproteins; D004958:Estradiol; D015127:9,10-Dimethyl-1,2-benzanthracene; D000242:Cyclic AMP